C3a receptor

C3a receptor (also known as C3AR1) is a G protein-coupled receptor that in humans is encoded by the C3AR1 gene. The C3a receptor is a protein that is part of the complement system, a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear microbes and damaged cells from an organism.

Function

The C3a receptor is a cell surface protein that is activated by the binding of C3a, one of the proteins produced during the activation of the complement system. This binding triggers a series of intracellular events that lead to the immune response. The C3a receptor is expressed on a variety of immune cells, including neutrophils, eosinophils, macrophages, and mast cells.

Clinical significance

Alterations in the C3a receptor have been associated with a variety of diseases, including asthma, rheumatoid arthritis, and lupus. In addition, the C3a receptor has been implicated in the progression of certain types of cancer. Therefore, the C3a receptor is considered a potential therapeutic target for the treatment of these diseases.

Research

Research on the C3a receptor is ongoing, with studies focusing on understanding the precise role of this receptor in the immune response and in disease progression. In addition, efforts are being made to develop drugs that can modulate the activity of the C3a receptor, with the aim of developing new treatments for diseases in which this receptor is involved.

See also

• Complement system
• G protein-coupled receptor
• C3a
• Immune system

References

This GPCR-related article is a stub. You can help WikiMD by expanding it.

This immune system related article is a stub. You can help WikiMD by expanding it.